---
document_datetime: 2024-12-02 17:32:51
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/eribulin-baxter-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: eribulin-baxter-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 0.9850185
conversion_datetime: 2025-12-27 19:36:28.6923
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Eribulin Baxter

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                                                                          | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary                                                                                                                                                                                                                                                                                       |
|----------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IB/0001              | C.I.3.z - Change(s) in the SPC, Labelling or PL intended to implement the outcome of a procedure concerning PSUR or PASS or the outcome of the assessment done under A 45/46 - Other variation | 20/11/2024                          |                                             | SmPC and PL                      | Update of Section 4.6 of the SmPC \"pregnancy, breastfeeding and fertility\" section and update of the PL to align with the same change to the reference product. In addition, the MAH has taken this opportunity to implement the change Eribulin to Eribulina in the ES annexes as requested. |

<!-- image -->

<!-- image -->